Lv4
480 积分 2024-04-11 加入
Targeted Treatments for Vascular Malformations: Current State of the Art
3小时前
求助中
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
1个月前
已完结
Capecitabine plus gemcitabine in thymic epithelial tumors: Final analysis of a phase II trial
6个月前
已完结
PIK3CA in cancer: The past 30 years
7个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
